The BODs have reviewed and approved the FY26 budget that is presented here to the membership.
The Finance and Investment Subcommittee (FISC) reviewed, prioritized, and approved the proposed budget submitted by the staff. The Secretary-Treasurer presented this budget to the Executive Committees (ECs) of the AAO-HNS/F Boards of Directors (BODs) for the fiscal year, July 1, 2025–June 30, 2026 (FY26), for their consideration. Following the presentation and ensuing discussion, the ECs endorsed it for final review and approval by the BODs. During their April meeting, The BODs reviewed and conditionally approved the FY26 budget that is presented here to the membership.
Budgeting for FY26 represents the collaborative work of both the staff leadership and the members of the FISC to match stable funding to the mission we aspire to accomplish. The proposed FY26 budget is structured to meet the goals of the AAO-HNS/F Strategic Plan and continues to provide member services in the most effective and efficient way that provides the necessary support to members in their practice and patient care as well as the investment into the advancement and sustainability of the specialty.
Highlights of the FY26 Budget
The FY26 balanced budget is proposed at nearly USD 21,500,000, with over USD 21,000,000 funded from operating revenue and less than USD 500,000 funded from Board-designed Reserve Funds. Investment activity is not part of the operating budget and therefore is not considered in these figures.
Nearly 80% of FY26 revenue is driven primarily from Membership Dues (36%), Annual Meeting (32%), and Educational Products (12%). The remaining 20% of operating revenue comes from royalties from publishers of the journals and the Bulletin, royalties from our Academy Advantage partners, revenue from the Corporate Champions program, and donor contributions to the Foundation’s Annual Fund, and other donor contributions.
Changes in FY26 operating revenue compared with FY25 include, but are not limited to: an expected lower number of attendees at the 2025 Annual Meeting in Indianapolis, Indiana compared with the 2024 Annual Meeting in Miami, Florida; an increase in education product sales, mainly from the Otolaryngology Core Curriculum with expected sales to advanced practice providers, and increase in revenues from the Corporate Champions program owing to enhanced outreach to industry partners.
Overall operating expenses are budgeted slightly higher than the prior year mainly owing to inflation and targeted investments in technology infrastructure, education products, and Reg-ENT platform development.
Donor-restricted Net Assets are budgeted to support USD 234,000 of programming including CORE grants, Annual Meeting Guest Lectures, and travel grants for residents, humanitarian efforts, and International Visiting Scholars.
The budget is available to any Academy member who requests it in writing. Email requests to Lisa Holman, Senior Director, Finance, at bulletin@entnet.org.
